Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content ZJ Smith, C Lee, T Rojalin, RP Carney, S Hazari, A Knudson, K Lam, ... Journal of extracellular vesicles 4 (1), 28533, 2015 | 333 | 2015 |
Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298 L Bao, S Hazari, S Mehra, D Kaushal, K Moroz, S Dash The American journal of pathology 180 (6), 2490-2503, 2012 | 329 | 2012 |
Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model L Bao, A Haque, K Jackson, S Hazari, K Moroz, R Jetly, S Dash The American journal of pathology 178 (2), 838-852, 2011 | 189 | 2011 |
3D plasmonic nanobowl platform for the study of exosomes in solution C Lee, RP Carney, S Hazari, ZJ Smith, A Knudson, CS Robertson, ... Nanoscale 7 (20), 9290-9297, 2015 | 177 | 2015 |
Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis Y Wang, S Shenouda, S Baranwal, R Rathinam, P Jain, L Bao, S Hazari, ... Molecular cancer 10, 1-11, 2011 | 98 | 2011 |
Multispectral optical tweezers for biochemical fingerprinting of CD9-positive exosome subpopulations RP Carney, S Hazari, M Colquhoun, D Tran, B Hwang, MS Mulligan, ... Analytical chemistry 89 (10), 5357-5363, 2017 | 91 | 2017 |
Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes PK Chandra, AK Kundu, S Hazari, S Chandra, L Bao, T Ooms, GF Morris, ... Molecular Therapy 20 (9), 1724-1736, 2012 | 90 | 2012 |
Cellular delivery of PEGylated PLGA nanoparticles S Pamujula, S Hazari, G Bolden, RA Graves, DD Chinta, S Dash, ... Journal of Pharmacy and Pharmacology 64 (1), 61-67, 2012 | 88 | 2012 |
Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture F Gunduz, FM Aboulnasr, PK Chandra, S Hazari, B Poat, DP Baker, ... Virology Journal 9, 1-12, 2012 | 51 | 2012 |
Targeting tumor‐associated exosomes with integrin‐binding peptides RP Carney, S Hazari, T Rojalin, A Knudson, T Gao, Y Tang, R Liu, ... Advanced biosystems 1 (5), 1600038, 2017 | 48 | 2017 |
Interferons α, β, γ each inhibit hepatitis C virus replication at the level of internal ribosome entry site‐mediated translation S Dash, R Prabhu, S Hazari, F Bastian, R Garry, W Zou, S Haque, V Joshi, ... Liver International 25 (3), 580-594, 2005 | 43 | 2005 |
Stability of lyophilized siRNA nanosome formulations AK Kundu, PK Chandra, S Hazari, G Ledet, YV Pramar, S Dash, ... International journal of pharmaceutics 423 (2), 525-534, 2012 | 42 | 2012 |
Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA … S Hazari, SK Acharya, SK Panda Journal of virological methods 116 (1), 45-54, 2004 | 41 | 2004 |
Development and optimization of nanosomal formulations for siRNA delivery to the liver AK Kundu, PK Chandra, S Hazari, YV Pramar, S Dash, TK Mandal European journal of pharmaceutics and biopharmaceutics 80 (2), 257-267, 2012 | 39 | 2012 |
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis PK Chandra, F Gunduz, S Hazari, R Kurt, R Panigrahi, B Poat, D Bruce, ... PLoS One 9 (9), e108616, 2014 | 37 | 2014 |
Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway S Hazari, PK Chandra, B Poat, S Datta, RF Garry, TP Foster, G Kousoulas, ... Virology journal 7, 1-16, 2010 | 37 | 2010 |
Treatment of hepatitis C virus infection in patients of northern India S Hazari, SK Panda, SD Gupta, Y Batra, R Singh, SK Acharya Journal of gastroenterology and hepatology 19 (9), 1058-1065, 2004 | 36 | 2004 |
Comparative evaluation of indirect and sandwich ELISA for the detection of antibodies to bovine respiratory syncytial virus (BRSV) in dairy cattle S Hazari, HK Panda, BC Kar, BR Das Comparative immunology, microbiology and infectious diseases 25 (1), 59-68, 2002 | 36 | 2002 |
Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon S Hazari, L Taylor, S Haque, RF Garry, S Florman, R Luftig, F Regenstein, ... Virology Journal 4, 1-13, 2007 | 34 | 2007 |
Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1 S Datta, S Hazari, PK Chandra, M Samara¹, B Poat, F Gunduz, ... Virology journal 8, 1-18, 2011 | 26 | 2011 |